Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AABFU89957
Magnesium Glycinate Bisgycinate + Vitamine B6 Haute concentration 1422 mg 180 Gélules Origine Angleterre
hero
3P
PARAPHARMACIE LIBRE-SERVICE
Last 4 weeks demand
9
▲ 12.5% vs prev 4w
Offer Stock
12
Σ Stock across 1 live offer (1P + 3P) · 2026-10-02
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-02 snapshot
Unit price
MAD 273
avg of last 30 sells · latest 2026-09-27
AABFU89957
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-09-28 · Total forecast: 257 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnesium Glycinate Bisgycinate + Vitamine B6 Haute concentration 1422 mg 180 Gélules Origine Angleterre · in the hero cohort · last 4 weeks 9 units, trending up +12.5% · on-hand 12 units
Signals the model saw
- Cohort: hero (364 days of history, 396 units sold over 52 weeks)
- Volatility (CV): 0.98 — moderate
- Recent trend: last 4w = 9 units · prev 4w = 8 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 0.8 units |
| Realistic forecast — next 4 weeks | 5.2 units |
| Realistic forecast — next 3 months | 67.3 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 12.8 units |
| Optimistic — next week | 11.2 units |
| Optimistic — next 4 weeks (reorder target) | 60.0 units |
| Optimistic — next 3 months (quarterly PO target) | 257.4 units |
| Legacy μ/wk (reorder pipeline) | 6.5 |
| Revenue exposure — optimistic, 3 months | MAD 70.3K |